Dr Toshinari Tamura joins board at FibroGen
This article was originally published in Scrip
Executive Summary
Dr Toshinari Tamura, recently retired representative director, executive vice-president and chief science officer ofAstellas Pharma, has joined the board of directors at FibroGen (US).